|
[1]
|
Lu, H., Niu, F., Liu, F., et al. (2017) Elevated Glypican-1 Expression Is Associated with an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma. Cancer Medicine, 6, 1181-1191. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Ren, B., Cui, M., Yang, G., et al. (2018) Tumor Microenvironment Participates in Metastasis of Pancreatic Cancer. Molecular Cancer, 17, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Jiang, Z., Zheng, X., Li, M., et al. (2023) Improving the Prognosis of Pancreatic Cancer: Insights from Epidemiology, Genomic Alterations, and Therapeutic Challenges. Frontiers in Medicine, 17, 1135-1169. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Ho, W.J., Jaffee, E.M. and Zheng, L. (2020) The Tumour Microenvironment in Pancreatic Cancer—Clinical Challenges and Opportunities. Nature Reviews Clinical Oncology, 17, 527-540. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Halbrook, C.J., Lyssiotis, C.A., Pasca di Magliano, M., et al. (2023) Pancreatic Cancer: Advances and Challenges. Cell, 186, 1729-1754. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Frappart, P.O. and Hofmann, T.G. (2020) Pancreatic Ductal Adenocarcinoma (PDAC) Organoids: The Shining Light at the End of the Tunnel for Drug Response Prediction and Personalized Medicine. Cancers, 12, Article 2750. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Hegde, S., Krisnawan, V.E., Herzog, B.H., et al. (2020) Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell, 37, 289-307.e289. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
Yang, M.W., Tao, L.Y., Jiang, Y.S., et al. (2020) Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma. Cancer Research, 80, 1991-2003. [Google Scholar] [CrossRef]
|
|
[9]
|
Choueiry, F., Torok, M., Shakya, R., et al. (2020) CD200 Promotes Immunosuppression in the Pancreatic Tumor Microenvironment. The Journal for ImmunoTherapy of Cancer, 8, e000189. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Xiong, Y., Si, Y., Feng, Y., et al. (2021) Prognostic Value of Lipid Metabolism-Related Genes in Head and Neck Squamous Cell Carcinoma. Immunity, Inflammation and Disease, 9, 196-209. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Ferrucci, V., Asadzadeh, F., Collina, F., et al. (2021) Prune-1 Drives Polarization of Tumor-Associated Macrophages (TAMs) within the Lung Metastatic Niche in Triple-Negative Breast Cancer. iScience, 24, Article 101938. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Li, C.W., Lim, S.O., Chung, E.M., et al. (2018) Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1. Cancer Cell, 33, 187-201.e110.
|
|
[13]
|
Sun, Y., Liu, T., Xian, L., et al. (2020) B3GNT3, a Direct Target of miR-149-5p, Promotes Lung Cancer Development and Indicates Poor Prognosis of Lung Cancer. Cancer Management and Research, 12, 2381-2391. [Google Scholar] [CrossRef]
|
|
[14]
|
Hsien Lai, S., Zervoudakis, G., Chou, J., et al. (2020) PDE4 Subtypes in Cancer. Oncogene, 39, 3791-3802. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Bao, Z., Feng, Y., Wang, H., et al. (2014) Integrated Analysis Using Methylation and Gene Expression Microarrays Reveals PDE4C as a Prognostic Biomarker in Human Glioma. Oncology Reports, 32, 250-260. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Zhai, L., Ladomersky, E., Lenzen, A., et al. (2018) IDO1 in Cancer: A Gemini of Immune Checkpoints. Cellular & Molecular Immunology, 15, 447-457. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Cheong, J.E. and Sun, L. (2018) Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy—Challenges and Opportunities. Trends in Pharmacological Sciences, 39, 307-325. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Zhang, Z., Wang, Q., Zhang, M., et al. (2021) Comprehensive Analysis of the Transcriptome-Wide m6A Methylome in Colorectal Cancer by MeRIP Sequencing. Epigenetics, 16, 425-435. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Zhang, Q., Li, T., Wang, Z., et al. (2020) lncRNA NR2F1-AS1 Promotes Breast Cancer Angiogenesis through Activating IGF-1/IGF-1R/ERK Pathway. Journal of Cellular and Molecular Medicine, 24, 8236-8247. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Zhang, Z. and Zhang, X. (2021) Identification of m6A-Related Biomarkers Associated with Prognosis of Colorectal Cancer. Medical Science Monitor, 27, e932370. [Google Scholar] [CrossRef]
|
|
[21]
|
Zhao, R., Peng, C., Song, C., et al. (2020) BICC1 as a Novel Prognostic Biomarker in Gastric Cancer Correlating with Immune Infiltrates. International Immunopharmacology, 87, Article 106828. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Wang, H., Deng, Q., Lv, Z., et al. (2023) Retraction Note: N6-Methyladenosine Induced Mir-143-3p Promotes the Brain Metastasis of Lung Cancer via Regulation of VASH1. Molecular Cancer, 22, Article No. 132. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Marcussen, M., Sønderkær, M., Bødker, J.S., et al. (2018) Oral Mucosa Tissue Gene Expression Profiling before, during, and after Radiation Therapy for Tonsil Squamous Cell Carcinoma. PLOS ONE, 13, e0190709. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Saito, Y., Li, L., Coyaud, E., et al. (2019) LLGL2 Rescues Nutrient Stress by Promoting Leucine Uptake in ER Breast Cancer. Nature, 569, 275-279. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Adams, E.J., Karthaus, W.R., Hoover, E., et al. (2019) FOXA1 Mutations Alter Pioneering Activity, Differentiation and Prostate Cancer Phenotypes. Nature, 571, 408-412. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Liang, E., Lu, Y., Shi, Y., et al. (2020) MYEOV Increases HES1 Expression and Promotes Pancreatic Cancer Progression by Enhancing SOX9 Transactivity. Oncogene, 39, 6437-6450. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Malik, A.S., Boyko, O., Aktar, N., et al. (2001) A Comparative Study of MR Imaging Profile of Titanium Pedicle Screws. Acta Radiologica, 42, 291-293. [Google Scholar] [CrossRef] [PubMed]
|